Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect

Acta Derm Venereol. 2010 May;90(3):311-2. doi: 10.2340/00015555-0839.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / immunology
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Erythema / chemically induced
  • Etanercept
  • Humans
  • Immunoglobulin G / adverse effects*
  • Infliximab
  • Lichenoid Eruptions / chemically induced*
  • Lichenoid Eruptions / pathology
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor
  • Skin / drug effects*
  • Skin / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept